ProGen

ProGen

Developing next-generation innovative bio new drugs.

HQ location
Seoul, South Korea
Launch date
Enterprise value
$65m
Company register number
1358128583
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
investor

€0.0

round
investor

€0.0

Valuation: €0.0

round
*

KRW22.0b

Convertible
Total Funding000k
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads